A LABORATORY CHARACTERISTICS AND PRESENTATION OF MULTI-ORGAN AFFECTION AMONG HOSPITALIZED PATIENTS WITH SARS-CoV-2 INFECTION IN PUBLIC HOSPITAL IN BITOLA
In December 2019, a highly infectious disease, ie, pneumonia caused by the coronavirus disease SARS-CoV-2, occurred in Wuhan, China, and the World Health Organization has declared its ongoing outbreak a pandemic. The clinical laboratory plays a key role in supporting the monitoring and management of Covid 19 disease. Our study describes the laboratory characteristics of 103, Covid 19 positive patients hospitalized in the public hospital Trifun Panovski in the period April - June 2020. Only two patients died as a result of the Covid 19. The most common laboratory abnormalities were: elevated lactate dehydrogenase (LDH) and C-reactive protein (CRP). Leukocytosis was found in 23,3%, and leucopenia in 3% of patients with Covid 19. Covid 19 infection can be associated with myocardial injury, heart failure, vascular inflammation, myocarditis, cardiac arrhythmias, and hypoxic encephalopathy. We found increased values of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and γ –glutamyltransferase (γ –GT) in 35 – 50% of patients. We detected affected renal function in 10% of our patients with Covid 19.We identified potential biomarkers of disease severity. Our results provide guidance in risk assessment, clinical monitoring and therapy decision-making processes
Keywords: Covid 19, laboratory findings, multi organ failure.
2. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395:1054-62.
4. Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Trav Med 2020; 27(2):taaa021
5. Zhu N, Zhang D, Wang W, Li, X, Yang B, Song J, t al. A novel coronavirus from patients with pneumonia in China. N Engl J Med 2020; 20,382(8):727-733.
6. Chan JFW, Yuan S, Kok KH, To KKW, Chu H, Yang JX, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020; 395:514–23.
7. Fang J, Liehua D, Liangqing Z, Yin C, Chi W, Cheung, Zhengyuan X. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). J Gen Intern Med 2020; 35(5):1545–1549.
8.Huang C, Wang Y, Li X., Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:497–506.
9. Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, et al. Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). J of General Internal Medicine 2020; 35(5):1545-1549.
10. Lin JW, Han TW, Woodward M, Anderson CS, Zhou H, et al. The impact of 2019 novel coronavirus on heart injury: a systematic review and meta-analysis. Prog Cardiovasc Dis. 2020; YPCAD-01081.
11. Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clinical Chemistry and Laboratory Medicine 2020; 58 (7).
12. Tanni F, Akker E, Zaman MM, Figueroa N, Tharian B, Hupart KH. Eosinopenia and COVID-19. J Am Osteopath Assoc 2020; 120, 504-508.
13.Henry BM, De Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in corona virus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med 2020; 58(7): 1021–1028.
14. Recep O, Yeşim T, Akif A.COVID-19: pathogenesis, genetic polymorphism, clinical features and laboratory findings. Turk J Med Sci 2020; 50:638-657.
15. Jie L, Jian-Gao F. Characteristics and mechanism of liver injury in 2019 coronavirus. Disease J Clin Transl Hepatol 2020; 28; 8(1): 13–17.
16.Henry BM, Vikse J. Clinical cvharacteristics of Covid-19 in China. N Engl J Med 2020; 382(19):1860-1861.
17.Piero P, Marcin K, Antonia M, Frank L, Agostino DC. Hepatic consequences of COVID-19 infection. Lapping or biting? Eur JH Intern Med 2020; 77: 18-24.
18.Qingxian C, Deliang H, Hong Y, Zhibin Z, Zhang X,Yinan Su, et al. COVID-19: Abnormal liver function tests. J Hepatol 2020; 73(3):566–574.
19. Cai Q, Huang D, Yu H, Zhu Z, Xia Z et al. COVID-19: abnormal liver function tests. J of Hepat 2020;73(3):566-574.
20.Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382:1708-1720.
21. Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med 2020; 58 (7).
22. Santoso A, Pranata R, Wibowo A, Al-Farabi MJ, Huang I et al. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: a meta-analysis. Am J Emerg Med 2020; S0735-6757(20)30280-1.
23 Chen G, Wu D, Guo W, Cao Y, Huang D et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 2020; 130(5):2620-2629.
24. Akhmerov A, Marbán E. COVID-19 and the Heart. Circ Res 2020; 126(10):1443-1455.
25. Tahir F, Bin Arif T, Ahmed J, et al. Cardiac manifestations of coronavirus disease 2019(COVID-19), a comprehensive review. Cureus 2020; 12(5): e8021.
26. Kenneth IZ, Gong F, Wen‐Yue L, Giovanni T, Christopher DB, Ming‐Hua Z. Extra-pulmonary complications of COVID-19: a multi-system disease? J Med Vir 2020;1-13.
27. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. Jama 2020; 323(11):1061-1069.
28. Yang X, Jin Y, Li R, Zhang Z, Sun R, Chen D. Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis. Crit Care 2020; 24(1):356.
29. Paces J, Strizova Z, Smrz D, Cerny J. COVID-19 and the immune system. Physiol Res 2020; 16;69(3):379-388.
30.Young BE, Ong SWX, Kalimuddin S, Low JG, Tan SY et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA 2020; 323 (15): 1488-1494.